Biodexa Pharmaceuticals Plc (NASDAQ:BDRX – Get Free Report)’s share price dropped 3.5% during mid-day trading on Monday . The stock traded as low as $1.24 and last traded at $1.38. Approximately 178,356 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 595,523 shares. The stock had previously closed at $1.43.
Biodexa Pharmaceuticals Stock Down 3.5 %
The business’s 50 day moving average price is $2.34 and its 200-day moving average price is $3.99.
About Biodexa Pharmaceuticals
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.
Featured Articles
- Five stocks we like better than Biodexa Pharmaceuticals
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- Growth Stocks: What They Are, What They Are Not
- Why Call Option Traders Are Targeting This Dividend ETF Now
- What is a Low P/E Ratio and What Does it Tell Investors?
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
